Virtus ETF Advisers’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24,099	Closed	-$70.6K	–	420
2024 Q4	$70.6K	Sell	24,099 -3,579	-13%	-$9.97K	0.03%	373
2024 Q3	$72K	Buy	27,678 +493	+2%	+$1.37K	0.03%	425
2024 Q2	$80.5K	Buy	27,185 +11,373	+72%	+$43K	0.04%	404
2024 Q1	$71.6K	Sell	15,812 -1,082	-6%	-$5.52K	0.04%	409
2023 Q4	$96.5K	Buy	16,894 +3,509	+26%	+$16.3K	0.06%	374
2023 Q3	$61.6K	Sell	13,385 -1,329	-9%	-$8.09K	0.04%	402
2023 Q2	$95.1K	Buy	14,714 +4,731	+47%	+$32.3K	0.06%	409
2023 Q1	$75.3K	Sell	9,983 -3,844	-28%	-$34.9K	0.04%	394
2022 Q4	$140K	Buy	13,827 +1,951	+16%	+$22.5K	0.07%	366
2022 Q3	$117K	Buy	11,876 +92	+0.8%	+$1.01K	0.05%	401
2022 Q2	$125K	Hold	11,784	–	–	0.05%	369
2022 Q1	$115K	Sell	11,784 -698	-6%	-$6.61K	0.05%	278
2021 Q4	$178K	Buy	12,482 +3,818	+44%	+$57.9K	0.07%	252
2021 Q3	$174K	Sell	8,664 -447	-5%	-$7.9K	0.08%	301
2021 Q2	$200K	Buy	+9,111	New	+$251K	0.08%	346